Secondary prevention for ischaemic heart disease can be defined as a comprehensive set of measures, aiming to reduce the recurrence of cardiovascular disease and to improve long-term prognosis. Despite its proven efficacy, uptake and adherence rates remain poor. This paper summarises the available European recommendations for secondary prevention in varying ischaemic heart disease populations, including those patients with specific co-morbidities. The scientific evidence supporting these recommendations is provided. The article relates to the European Association of Preventive Cardiology, the Acute Cardiovascular Care Association and the Council on Cardiovascular Nursing and Allied Professions Secondary Prevention After Acute Myocardial Infarction framework in that it clarifies accurately who needs secondary prevention.
PiepoliMFHoesAWAgewallS. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Eur Heart J2016; 37: 2315–2381.
2.
PiepoliMFCorràUAdamopoulosS. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: A policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention and Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol2014; 21: 664–681.
3.
Bjarnason-WehrensBMcGeeHZwislerAD. Cardiac rehabilitation in Europe: Results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil2010; 17: 410–418.
4.
European Heart Network. European cardiovascular disease statistics 2017, www.ehnheart.org/cvd-statistics.html (2016, accessed 14 November 2016).
PedersenFButrymovichVKelbaekH. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol2014; 64: 2101–2108.
7.
JernbergTHasvoldPHenrikssonM. Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J2015; 36: 1163–1170.
8.
KotsevaKWoodDDe BacquerD. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
9.
ClarkAKing-ShierKDuncanA. Factors influencing referral to cardiac rehabilitation and secondary prevention programs: A systematic review. Eur J Prev Cardiol2012; 20: 692–700.
10.
PiepoliMFCorràUDendaleP. Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Prev Cardiol2016; 23: 1994–2006.
11.
StegGJamesSKAtarD. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J2012; 33: 2569–2619.
12.
RoffiMPatronoCColletJP. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J2016; 37: 267–315.
13.
MontalescotGSechtemUAchenbachS. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J2013; 34: 2949–3003.
14.
RauchBDavosCHDohertyP. The prognostic effect of cardiac rehabilitation in the era of acute revascularization and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies – The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol2016; 23: 1914–1939.
15.
AndersonLOldridgeNThompsonDR. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane systematic review and meta-analysis. J Am Coll Cardiol2016; 67: 1–12.
16.
GiallauriaFVigoritoCTramarinR. ISYDE-2008 Investigators of the Italian Association for Cardiovascular Prevention, Rehabilitation and Prevention. Cardiac rehabilitation in very old patients: Data from the Italian Survey on Cardiac Rehabilitation-2008 [ISYDE-2008]. J Gerontol A Biol Sci Med Sci2010; 65: 1353–1361.
17.
Giné-GarrigaMRoqué-FígulsMColl-PlanasL. Physical exercise interventions for improving performance-based measures of physical function in community-dwelling, frail older adults: A systematic review and meta-analysis. Arch Phys Med Rehabil2014; 95: 753–769.
18.
Weening-DijksterhuisEde GreefMHScherderEJ. Frail institutionalized older persons: A comprehensive review on physical exercise, physical fitness, activities of daily living, and quality-of-life. Am J Phys Med Rehabil2011; 90: 156–168.
19.
Artaza-ArtabeISáez-LópezPSánchez-HernándezN. The relationship between nutrition and frailty: Effects of protein intake, nutritional supplementation, vitamin D and exercise on muscle metabolism in the elderly. A systematic review. Maturitas2016; 93: 89–99.
20.
De CaterinaRMadonnaRSourijH. Glycaemic control in acute coronary syndromes: Prognostic value and therapeutic options. Eur Heart J2010; 31: 1557–1564.
21.
RydénLGrantPJAnkerSD. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – summary. Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Diab Vasc Dis Res2014; 11: 133–173.
22.
ColbergSRSigalRJFernhallB. Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement executive summary. Diabetes Care2010; 33: 2692–2696.
23.
VanheesLGeladasNHansenD. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular risk factors: Recommendations from the EACPR. Part II. Eur J Prev Cardiol2012; 19: 1005–1033.
24.
SnowlingNJHopkinsWG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: A meta-analysis. Diabetes Care2006; 29: 2518–2527.
25.
SigalRJKennyGPBouleNG. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: A randomized trial. Ann Intern Med2007; 147: 357–369.
26.
VöllerHGittAJannowitzC. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting. Eur J Prev Cardiol2014; 21: 1125–1133.
27.
TakayaYKumasakaRArakawaT. Impact of cardiac rehabilitation on renal function in patients with and without chronic kidney disease after acute myocardial infarction. Circ J2014; 78: 377–384.
PonikowskiPVoorsAAAnkerSD. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J2016; 37: 2129–2200.
30.
MoscaLBankaCLBenjaminEJ. Evidence-based guidelines for cardiovascular disease prevention in women. 2007 update. J Am Coll Cardiol2007; 49: 1230–1250.
31.
DanielsKMArenaRLavieCJ. Cardiac rehabilitation for women across the lifespan. Am J Med2012; 125. 937.e1-e7.
